Related Experiment Videos
Evaluation of column technology for direct antiglobulin testing
J M Moulds1, L Diekman, T D Wells
1Division of Rheumatology and Clinical Immunogenetics, University of Texas-Houston Medical School, 6431 Fannin, MSB 5.262, Houston, TX 77030, USA.
Immunohematology
|September 21, 2004
Summary
Microcolumn technology may be too sensitive for direct antiglobulin testing (DAT). This study found column techniques detected clinically insignificant weakly positive DAT results not seen with manual methods.
Area of Science:
- Immunology
- Clinical Chemistry
- Hematology
Background:
- Direct antiglobulin testing (DAT) is crucial for diagnosing hemolytic anemias.
- Microcolumn technologies offer potential automation but raise questions about sensitivity.
Purpose of the Study:
- To evaluate the sensitivity and clinical relevance of microcolumn technologies for DAT.
- To compare Sephadex gel and protein A/G columns against manual DAT methods.
Main Methods:
- Studied 228 autoimmune disease patient samples and 30 healthy controls.
- Compared Sephadex and protein A/G column techniques with manual methods.
- Utilized rabbit or murine polyspecific reagents for testing.
Main Results:
- Column techniques identified additional weakly positive DAT results (15-22%) in samples negative by manual methods.
- Observed poor correlation (r = 0.40-0.61) between column and manual DAT results.
- Acid eluates from these samples were negative, suggesting non-specific reactions.
Conclusions:
- Microcolumn technology may exhibit excessive sensitivity for DAT.
- Column techniques might detect clinically insignificant weakly positive DAT results.
- Further validation is needed to reconcile column and manual DAT findings.